pilocarpine has been researched along with Urinary Bladder, Overactive in 4 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We enrolled patients with overactive bladder symptoms in a multicenter, randomized, double-blind, parallel, active control study." | 2.90 | Efficacy and Safety of Tolterodine and Pilocarpine in Patients with Overactive Bladder. ( Choo, MS; Kim, HG; Kim, JH; Kim, KH; Kim, SO; Kim, SW; Ko, KJ; Lee, JZ; Lee, KS; Min, KS; Oh, SJ; Seo, JT, 2019) |
| " The combination was well tolerated, and the adverse effects observed were consistent with the known safety profiles of tolterodine and pilocarpine." | 2.79 | Clinical safety, tolerability and efficacy of combination tolterodine/pilocarpine in patients with overactive bladder. ( Dmochowski, RR; Duchin, K; Paborji, M; Staskin, DR; Tremblay, TM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, KJ | 2 |
| Kim, KH | 2 |
| Kim, SW | 2 |
| Kim, SO | 2 |
| Seo, JT | 2 |
| Choo, MS | 2 |
| Lee, JZ | 2 |
| Oh, SJ | 2 |
| Kim, HG | 2 |
| Min, KS | 2 |
| Kim, JH | 2 |
| Lee, KS | 2 |
| Malik, RD | 1 |
| Dmochowski, RR | 1 |
| Staskin, DR | 1 |
| Duchin, K | 1 |
| Paborji, M | 1 |
| Tremblay, TM | 1 |
2 trials available for pilocarpine and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Efficacy and Safety of Tolterodine and Pilocarpine in Patients with Overactive Bladder.
Topics: Aged; Cholinergic Antagonists; Double-Blind Method; Drug Combinations; Female; Humans; Incidence; Ma | 2019 |
Clinical safety, tolerability and efficacy of combination tolterodine/pilocarpine in patients with overactive bladder.
Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Hum | 2014 |
2 other studies available for pilocarpine and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Editorial Comment.
Topics: Humans; Pilocarpine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
Reply by Authors.
Topics: Humans; Pilocarpine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |